Libra Therapeutics’ $29 Million Series A Financing

Wilson Sonsini Goodrich & Rosati advised Libra Therapeutics on the deal. Libra Therapeutics launched to develop novel drug candidates focused on restoring the cellular balance lost…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Ambrogio Visconti

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here